Skip to main content
. 2020 Apr 15;20:312. doi: 10.1186/s12885-020-06794-5

Fig. 3.

Fig. 3

Proteomic data validation. a&b CRPs involved in “pathways in cancer” were validated via western blotting (cropping of blots, full-length blots are presented in Fig. S4) (a) and immunofluorescent microscopy (b) following CDR1as knockdown in 293 T cells. Scale bar, 10 μm. (c) miR-7 targets among these CRPs